Advertisement
Advertisement

INTS

INTS logo

Intensity Therapeutics, Inc. Common stock

4.16
USD
Sponsored
-0.09
-2.12%
Aug 07, 15:58 UTC -4
Closed
exchange

After-Market

4.22

+0.06
+1.44%

Intensity Therapeutics, Inc. Common stock Profile

About

Intensity Therapeutics Inc. is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. Intensity leverages its DfuseRx(SM) technology platform to create new, proprietary drug formulations, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity Therapeutics Inc. is based in WESTPORT, Conn.

Info & Links

CEO

Lewis H. Bender

Headquarters

1 ENTERPRISE DRIVE, SUITE 430
SHELTON, CT 06484, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.intensitytherapeutics.com

Auditor

EisnerAmper LLP

Share holders

31

Employees

7

Intensity Therapeutics, Inc. Common stock Statistics

Valuation Measures

Market Capitalization2

11.41M

Enterprise Value

1.26M

Enterprise Value/EBITDA(ttm)

-0.11

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.13

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-136.82%

Return on Invested Capital(ttm)

-197.61%

Return on Assets(ttm)

-105.82%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-11.08M

Net Income Available to Common(ttm)

-10.69M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

2.76

52-Week Change

-33.97%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

2.70M

Dividend Yield

0.00%

Float4

2.50M

% Held by Insiders

7.60%

% Held by Institutions

3.74%

Balance Sheet

Total Cash(mrq)

10.24M

Total Cash Per Share(mrq)

3.79

Total Debt(mrq)

102.00K

Total Debt/Equity(mrq)

1.02%

Current Ratio(mrq)

4.86%

Quick Ratio(mrq)

4.86%

Book Value Per Share(mrq)

3.93

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.72

Free Cash Flow(ytd)

-1.83M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement